Sanofi’s Patents on Cancer Drug Taxotere Invalidated

Sanofi’s two patents on the cancer drug Taxotere were ruled invalid and unenforceable by a U.S. court today in a victory for generic-drug makers Hospira and Apotex.
Bloomberg